What is CBGV?
Cannabigerovarin, or CBGV, is a non-psychoactive cannabinoid acid. As a derivative of cannabigerol, it is part of the CBG class.
This cannabinoid shows much therapeutic potential. As a derivative of CBG, it is theorized it could potentially benefit the human body in similar ways. Additionally, research into CBGV shows that it may potentiate the effects of other cannabinoids as they interact with the CB1 and CB2 receptors of the endocannabinoid system.
Studies on CBGV
Some studies suggest that CBGV might enhance the body’s response to CBD, potentially amplifying its effects. There’s also interest in CBGV’s potential role in modulating the effects of THC, which could be beneficial for those exploring the supportive qualities of THC without its pronounced psychoactive effects. CBGV might interact with the endocannabinoid system in ways that enhance the effects of other cannabinoids.
While there’s interest in the potential supportive qualities of CBGV, such as promoting comfort and supporting a healthy inflammation response, it’s essential to note that research is ongoing. Some cannabinoids, including CBGV, have been studied for their potential role in supporting cellular health. However, more comprehensive research is needed to fully understand CBGV’s potential benefits.